Posted on 11/1/18
Cigna Reports Strong Third Quarter 2018 Results, Raises Outlook
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna Corporation (NYSE: CI) today reported third quarter 2018 results, with strong performance across all of our businesses.“Cigna continues to provide more affordable, personalized . . .
Posted on 11/1/18
Curis Reports Third Quarter 2018 Financial Results
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported financial results for the third . . .
Posted on 11/1/18
IDEXX Laboratories Announces Third Quarter Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, reports revenues for the third quarter of 2018 . . .
Posted on 11/1/18
BioMarin Keeps on Pace for Its $2 Billion Goal
BioMarin Pharmaceutical (NASDAQ:BMRN) continues to see solid growth from its stable of drugs to treat orphan diseases as it pushes toward its goal for a combined . . .
Posted on 10/31/18
AgaMatrix Enters Strategic Partnership with Arcadia Group
AgaMatrix and Arcadia Group announced today a strategic partnership leveraging AgaMatrix's proprietary blood glucose monitoring (BGM) technology for the Choice line of diabetes products marketed by . . .
Posted on 10/31/18
Remedy Triples Size of its Episodes of Care Program with Healthcare Providers
Proven Success with Medicare’s Bundled Payments for Care Improvement Program Sets Stage for Success in Private Insurance Market With Self-Funded Employers, Commercial Payers and Providers Remedy, the . . .
Posted on 10/31/18
Gilead Sciences and Tango Therapeutics Announce Strategic Collaboration
FOSTER CITY, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Tango Therapeutics, Inc., a company focused on the discovery and development of novel cancer . . .
Posted on 10/31/18
LabShares Newton Launches Near Capacity and Announces Expansion Plans
NEWTON, Mass.--(BUSINESS WIRE)--LabShares Newton, an office and laboratory incubator for emerging biotechnology and life science companies, announced the launch of its first location in Newton. LabShares . . .
Posted on 10/31/18
ArQule Reports Third Quarter 2018 Financial Results
BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (Nasdaq: ARQL) today announced its financial results for the third quarter of 2018.For the quarter ended September 30, 2018, the Company reported . . .
Posted on 10/31/18
Novartis May Beat Ironwood Pharmaceuticals to the Punch
Novartis (NYSE:NVS) reported updated, post-hoc data for its sickle cell disease drug, crizanlizumab, in early October, and it plans to file this drug for regulatory approval . . .
Posted on 10/30/18
Biological Industries USA Adds Human Mesenchymal Cells to its Stem Cell Portfolio in Partnership with StemExpress
CROMWELL, Conn. & FOLSOM, Calif.--(BUSINESS WIRE)--Biological Industries USA (BI-USA), a division of Biological Industries Beit Haemek Israel (BI), and StemExpress announce a strategic partnership for the . . .
Posted on 10/30/18
MC Healthcare Signs Partnership Agreement With Caresyntax
Caresyntax, a surgical automation, analytics, and AI technology company, announced today that MC Healthcare, a subsidiary company of Mitsubishi Corporation, acquired a minority stake of caresyntax. . . .
Posted on 10/30/18
Blueprint Medicines Reports Third Quarter 2018 Financial Results
Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today reported financial results and provided . . .
Posted on 10/30/18
Aetna Reports Third-Quarter 2018 Results
HARTFORD, Conn.--(BUSINESS WIRE)--Aetna (NYSE: AET) announced third-quarter 2018 net income(1) of $1.0 billion, or $3.03 per share. Adjusted earnings(2) for third-quarter 2018 were $977 million, or . . .
Posted on 10/30/18
Vertex: Great Company But Too Pricey
SummaryVertex is a $42 bn market cap biotech company that showed unprecedented success over the last several years in the treatment of cystic fibrosis.We believe that . . .
Posted on 10/30/18
Vertex Pharmaceuticals Waits to Hit the Triple
Vertex Pharmaceuticals (NASDAQ:VRTX) continues to post substantial revenue growth, although many investors are rightfully looking ahead to its next-generation triple combinations for cystic fibrosis.Vertex Pharmaceuticals results: . . .
Posted on 10/29/18
Eli Lilly & Co. Reports RNAi Licensing & Research Collaboration with Dicerna Pharmaceuticals
Eli Lilly and Company (NYSE: LLY) and Dicerna Pharmaceuticals (NASDAQ: DRNA) today announced a global licensing and research collaboration focused on the discovery, development and commercialization . . .
Posted on 10/29/18
Lilly and Dicerna Announce RNAi Licensing and Research Collaboration
Eli Lilly and Company (NYSE: LLY) and Dicerna Pharmaceuticals (NASDAQ: DRNA) today announced a global licensing and research collaboration focused on the discovery, development and commercialization . . .
Posted on 10/29/18
SeraCare Announces Exclusive Partnership with AccuRef Diagnostics
SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today an exclusive partnership with AccuRef Diagnostics, a . . .
Posted on 10/29/18
Better Buy: Cara Therapeutics, Inc. vs. Scotts Miracle-Gro Company
What do Cara Therapeutics, Inc. (NASDAQ:CARA) and Scotts Miracle-Gro (NYSE:SMG)have in common? Very little.Both are often categorized as marijuana stocks. Cara receives the designation because of . . .
Posted on 10/29/18
This Big Pharma Bet Isn't Paying Off Yet -- and It's Costing You
You probably wouldn't care too much if your neighbor bought 1,000 lottery tickets that didn't win. But it might be a different story if his bet . . .
Posted on 10/29/18
AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated
At the moment, treatment options for cystic fibrosis are limited to drugs marketed by Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), but a deep-pocketed drugmaker just took a big . . .
Posted on 10/29/18
Immunomic Therapeutics Senior Director of Corporate Development to Present at Precision Lung Cancer World R&D Summit
BOSTON--(BUSINESS WIRE)--On Monday, October 29,Senior Director of Corporate Development at Immunomic Therapeutics Inc. Sia Anagnostou will speak at the Precision Lung Cancer World R&D Summit in . . .
Posted on 10/28/18
Gurnet Point Commences Cash Tender Offer for All Outstanding Shares of Corium International
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gurnet Point L.P. announced that a wholly-owned indirect subsidiary of Gurnet Point, Gurnet Merger Sub, Inc., has commenced the previously announced cash tender offer . . .
Posted on 10/28/18
Gamida Cell Prices IPO
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd., a leading cellular and immune therapeutics company, today announced the pricing of its initial public offering of 6,250,000 ordinary shares at a . . .

